Almost all the major hotel chains were outranked by a different type of lodging in the 2026 travel survey by the American ...

AstraZeneca (AZN) tozorakimab achieves primary endpoint in Phase III MIRANDA trial, reducing COPD exacerbations in smokers ...

From protein lattes to GLP-1 menus, brands are leaning hard into high-protein marketing as weight-loss drugs reshape what ...

Findings of a real-world study confirm guidelines that recommend physical therapy as first-line treatment; it has a slight edge over cognitive-behavioral therapy.

This is the first release of 36-week symptom response & tissue health data for the highest dose (Cohort 9) from the dose escalation portion of Eupraxia’s RESOLVE trial. At 36 weeks, patients in Cohort ...

A 67-year old woman from Tasmania was reported to be “unresponsive” in the water near Australia's Moreton Island on April 17, ...

The study, conducted around every 5 years, helps the county establish tax rates. On May 4, county leaders will discuss the ...

Aspirin for prevention of colorectal cancer shows uncertain long-term benefit and increases bleeding risk, requiring individualized risk assessment for treatment decisions.

While the safety was more manageable, questions remain about whether the combination would best antibody-drug conjugate ...

TheFly reported on April 1 that Evercore ISI analyst Gavin Clark-Gartner reduced the price target on MGTX from $20 to $18 ...

Fundsmith’s Terry Smith says passive funds are laying the foundations of a major investment disaster - is he right?

Clinically meaningful improvements in xerostomia symptoms measured by PRO Xerostomia Questionnaire (XQ) maintained out to 3 years post treatment with AAV-hAQP1 for both bilateral and unilateral ...